Zevra Therapeutics (ZVRA) EBT Margin Growth (1y) (2020 - 2026)
Zevra Therapeutics (ZVRA) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | 13,310.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,310.00 |
| Dec 31, 2025 | 20,663.00 |
| Sep 30, 2025 | 89,544.00 |
| Jun 30, 2025 | 74,840.00 |
| Mar 31, 2025 | 47,796.00 |
| Dec 31, 2024 | -1,560.00 |
| Sep 30, 2024 | -54,720.00 |
| Jun 30, 2024 | -42,000.00 |
| Mar 31, 2024 | -6,796.00 |
| Dec 31, 2023 | -530.00 |
| Sep 30, 2023 | -14,479.00 |
| Jun 30, 2023 | 172,051.00 |
| Dec 31, 2022 | -4,530.00 |
| Sep 30, 2022 | -11,768.00 |
| Jun 30, 2022 | -180,351.00 |
| Dec 31, 2021 | 10,187.00 |
| Sep 30, 2021 | 6,856.00 |
| Jun 30, 2021 | 3,932.00 |
| Mar 31, 2021 | 19,047.00 |
| Dec 31, 2020 | 23,408.00 |